Gene Therapy Weekly
Susan Hasty, Publisher
Table of Contents . . . June 24th, 1996
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Arthritis - Ex Vivo Therapy Suppresses Arthritis in Rabbit Model
Antisense Technology - Anticode Preclinical Results in Breast Cancer, Melanoma, and Lymphoma Presented
Breast Cancer - Suboptimal DNA Repair Predisposes to Cancer
Breast Cancer (Combination Therapies) - Viral Oncolysis/Gene Therapy Effective in Murine Model
Cancer Vaccines - Peptide Vaccine Elicits Immunity to Oncogenic Self Protein
Colon Cancer - Onconase Enhances Antitumor Effects of Vincristine
Diarrhea - Broad-Spectrum Vaccine Based on Mutant Cholera Toxin
Genetics - Breakthrough Application of PNA Technology in Telomere Biology Announced
Genetics - Scientists Seek Gene Drugs
HIV Gene Therapy - HIV-2 Mediated Inhibition of HIV-1: Potential Gene Therapy Approach
Hemophilia - Somatic Cell Therapy Furnishes Constant Blood Levels of Factor VIII
Industry News (Acquisitions) - Exclusive Rights Acquired to Gene Transfer Method
Industry News (Funding) - NIH Phase II Grant Received for HIV Therapeutics Development
Industry News (Joint Venture) - Research Alliance Expanded on BRCA1 Gene Link to Cancers
Mucosal Immunity - Intranasal Toxoplasma Subunit Vaccine Protects Against Brain Cysts
Cancer Vaccines - "Anti-Idiotype Antibody Vaccine (3H1) that Mimics the Carcinoembryonic Antigen (CEA) as Adjuvant Treatment."
Cancer Vaccines (Development) - "Efficient Ex-Vivo Generation of Functional Dendritic Cells (DCs) Utilizable for Tumor Vaccination from Blood Cell Transplants (BCT) in Cancer Patients."
Cancer Vaccines (IL-4) - "Murine Interleukin-4 (mIL-4)-Based Therapeutic Tumor Vaccines Generated by Transfection of Multiple Genes into a Poorly Immunogenic Tumor Cell Line."
Immunotherapy (IL-1) - "Active Specific Immunotherapy for Metastatic Colorectal Carcinoma (CRC): Phase I-II Study of an Allogeneic Cell Vaccine Plus Low Dose Interleukin-1 Alpha (IL-1).
Therapy (Anti-Viral) - "Treating AIDS Patients With HIV-Specific Transfer Factor."
Therapy (Kaposi's Sarcoma) - "Long-Term Use of DOX-SL (Stealth Liposomal Doxorubicin HCl) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma."
Antisense Technology - "Antisense Inhibition of Basic Fibroblast Growth Factor Induces Apoptosis in Vascular Smooth Muscle Cells."
Antisense Technology - "Oligodeoxynucleotides Inhibit Retinal Neovascularization in a Murine Model of Proliferative Retinopathy."
Cancer Vaccines - "p53 as a Target for Cancer Vaccines: Recombinant Canarypox Virus Vectors Expressing p53 Protect Mice Against Lethal Tumor Cell Challenge."
DNA Vaccines - "Preferential Induction of a Th-1 Immune Response and Inhibition of Specific IgE Antibody Formation by Plasmid DNA Immunization."
HIV Gene Therapy - "Inhibition of Human and Simian Immunodeficiency Virus Protease Function by Targeting Vpx-Protease-Mutant Fusion Protein into Viral Particles."
Joint Disease - "Direct Gene Delivery to Synovium: An Evaluation of Potential Vectors in vitro and in vivo."
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
